SMAD family member 2 and SMAD family member 3 (Smad2, Smad3)

Smad2 and Smad3 are intracellular proteins that function as transcription factors and principal effectors of the TGF-β/activin/nodal signaling pathway. Upon activation by upstream receptors, they become phosphorylated, form heteromeric complexes with Smad4, and translocate into the nucleus to regulate transcription of genes involved in cell proliferation, differentiation, embryonic development, and response to injury. While structurally similar, Smad2 and Smad3 have distinct DNA-binding properties and functional specificities, including differential roles in embryonic germ layer formation and neural development. Dysregulation of Smad2/3 signaling is linked to cancer, fibrosis, and developmental disorders. These proteins are often targeted therapeutically by agents that disrupt upstream TGF-β receptor activity or downstream nuclear effects[2][3][4]. The term "Smad2/3 signaling pathway elements" refers collectively to this family of response modulators, not to a singular molecular target.

Other names

Mothers against decapentaplegic homolog 2Mothers against decapentaplegic homolog 3R-Smad (receptor-regulated Smad; both Smad2 and Smad3 are R-Smads)Smad2/3 (when referenced together due to overlapping pathway roles[3][4])

Inhibition of Smad2/3 phosphorylation (by blocking TGF-β receptor kinase); Disruption of Smad2/3 nuclear translocation and DNA binding; Downregulation of target gene transcription